TB-500 Research
TB-500 is a synthetic peptide based on the active region of thymosin beta-4 (Tβ4), a naturally occurring actin-binding protein, studied in laboratory models for its role in cell migration, cytoskeletal dynamics, and vascular network formation. Offered solely as a research chemical.
Also known as: Thymosin Beta-4 fragment (Tβ4)
Thymosin beta-4 is the principal G-actin-sequestering peptide in many cell types, regulating the pool of monomeric actin available for cytoskeletal assembly. By binding G-actin, TB-500-type sequences influence cell motility. Research literature additionally associates Tβ4 with angiogenic and endothelial-migration activity.
Mechanism of Action
The defining biochemical feature of thymosin beta-4 is its actin-binding domain, which sequesters monomeric G-actin and thereby buffers the cellular pool that drives filament polymerization. This activity positions the peptide as a regulator of cytoskeletal remodeling and directed cell migration in experimental systems. The TB-500 fragment corresponds to the actin-binding region most associated with this function. Research studies have also linked Tβ4 to endothelial cell migration and capillary-like network formation in angiogenesis assays, and to modulation of inflammatory and cell-survival signaling in tissue-injury models. All mechanistic data are derived from cultured cells and experimental work and are provided for research reference rather than any human or therapeutic claim.
Research Applications
TB-500 and thymosin beta-4 fragments are commonly used as tool compounds in cytoskeletal and cell-migration research. Reported research applications include scratch-wound and transwell migration assays in cultured fibroblasts, keratinocytes, and endothelial cells; angiogenesis and vascular-regeneration models in experimental systems; and investigations of actin dynamics in cardiac and other tissue-injury systems. Researchers also study Tβ4 in the context of cellular stress responses, including reports characterizing it as an endogenous iron chelator. This compound is supplied exclusively for non-clinical experimentation and must not be administered to humans or used in any diagnostic or treatment context.
Handling & Research Considerations
TB-500 is generally distributed as a lyophilized powder, prepared with sterile or bacteriostatic water and stored frozen, with working solutions refrigerated and used promptly to preserve integrity. Identity and purity are typically confirmed by HPLC and mass spectrometry prior to experiments. Because the peptide acts on broadly conserved cytoskeletal machinery, researchers should define cell type, concentration, and migration or angiogenesis endpoints precisely to ensure reproducible results. Findings from one model system should not be generalized across tissues without supporting data, and no results in experimental systems or cells imply efficacy or safety in humans.
Applications at a glance
- G-actin binding and cytoskeletal dynamics research
- Cell-migration assays in cultured cells
- Angiogenesis and vascular network models in experimental systems
- Actin biology in tissue-injury research systems